News For: Cost Of A PacemakerRisk of colorectal cancer extremely low 5 years after a normal colonoscopy screening A study appearing in the Sep. 18 issue of the New England Journal of Medicine shows that among individuals with no colorectal neoplasia abnormal growths on initial screening colonoscopy, the five-year risk of colorectal cancer is extremely low. The data provides support for re-screening at an interval of five years or longer after a normal colonoscopic examination. A Prominent Democratic Fundraiser Passes Johnny Hayes, a prominent Democratic fundraiser and longtime confidant of former Vice President Al Gore, has died. He was 67. His family issued a statement through Deputy Gov. Stuart Brunson that that Hayes died of cancer on Saturday. Briefer radiation treatment effective for early breast cancer: study Shorter courses of radiation therapy work just as well as the longer standard therapy for women with early-stage breast cancer, according to the results of a Canadian-led trial. Redskins' Taylor won't play Sunday vs. Cowboys Washington Redskins defensive end Jason Taylor's streak of playing in 132 straight games will end this week, thanks to a medical procedure to alleviate pain and swelling on his leg this morning, according to ESPN's Chris Mortensen. New ICMA/CIGNA Guide for Local Government Managers Focuses on Improving Community Health and Reducing Costs Every year, five percent of healthy employees become sick as a result of aging, unhealthy lifestyle choices, or other risk factors, according to CIGNA, one of the nation's leading health service companies. When added to the ranks of employees who already suffer from disease, this five percent drives the annual cost of health care coverage even higher. Science fund doles out $54m Projects studying volcanic super-eruptions, the diet of moa, and cancer are among those getting a share of $54 million of government money made available in this year's Marsden Fund awards. Noted Medical Physicist to Document OSLD Superiority at ASTRO Landauer, Inc. NYSE: LDR, a recognized leader in personal and environmental radiation monitoring, today announced that noted medical physicist, Paul A. Jursinic, Ph.D., will be presenting at ASTRO his findings on the superiority of Landauer's Optically Stimulated Luminescence Dosimetry OSLD for clinical dosimetric measurements. Dr. Jursinic is renowned among health physicists for his ... Acupuncture Eases Breast Cancer Treatment Side Effects MONDAY, Sept. 22 HealthDay News -- Lifesaving treatments for breast cancer come at a cost -- many women experience hot flashes, fatigue, night sweats and more. Ceragenix Satisfies Conditions for $1 Million Milestone Payment under Supply and Distribution Agreement Ceragenix Pharmaceuticals, Inc. OTCBB:CGXP the "Company", a medical device company focused on infectious disease and dermatology, today announced that it had satisfied the conditions necessary for triggering a $1,000,000 milestone payment under its supply and distribution agreement with Dr. Reddy's Laboratories, Inc. "DRL" for the commercialization of EpiCeramR the "DRL Agreement". The ... Tuberculosis researchers discuss challenges, next steps for addressing XDR-TB, MDR-TB in Africa at TB symposium As many as 30% of people with drug-resistant tuberculosis can be successfully treated with first-line drugs, Paul van Helden of the University of Stellenbosch's Center of Excellence for Biomedical TB Research said recently while presenting research on drug-resistant TB at a TB symposium in Maputo, Mozambique, Africa Science News Service reports. |


